Law office of Brodsky & Smith, LLC announces that it is investigating potential claims against the Board of Directors of Chordiant Software, Inc (“Chordiant” or the “Company”) (Nasdaq: CHRD) relating to the proposed acquisition by Pegasystems, Inc. (“Pegasystems”). Under the terms of the offer, Chordiant shareholders would receive $5.00 for each share of Chordiant stock they own.

The investigation concerns possible breaches of fiduciary duty and other violations of state law related to the Chordiant board’s approval of the proposed acquisition. Specifically, Chordiant shareholders need additional information as to what actions the board took to adequately shop the Company given Chordiant’s recent rejection of an offer from CDC Software Corp.

If you own shares of Chordiant and wish to discuss the legal ramifications of the proposed transaction, or have any questions, you may e-mail or call the law office of Brodsky & Smith, LLC who will, without obligation or cost to you, attempt to answer your questions. You may contact Jason L. Brodsky, Esquire or Evan J. Smith, Esquire at Brodsky & Smith, LLC, Two Bala Plaza, Suite 602, Bala Cynwyd, PA 19004, by e-mail at investorrelations@brodsky-smith.com, or by calling toll free 877-LEGAL-90.